Doctors urge cannabis caution for children with chronic diseases

Catherine Jacobson is the director of clinical research at Tilray. She’s also a neuroscientist whose son has severe uncontrolled epilepsy. She said Tilray’s primary objective is to evaluate the effect of oral cannabinoids on seizure frequency in adults and the company wants to do this through a Health Canada-approved trial.

Read more in the Vancouver Sun